Evidence map›Paper›PMID 40164630›Full record

ArticleScientific reports2025

Design of a multi-epitope vaccine candidate against Vibrio cholerae.

Fatemeh Nouri Koupaei, Armity Kiumarsy, Mohammad Mahdi Feizi, Zohreh Vajdi, Seyed Edalat Pishkar, Mahsa Alem, Esmaeil Roohparvar Basmenj

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Proteome conserved multi-epitope-based vaccine construct against Nipah virus.Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fatemeh Nouri KoupaeiIslamic Azad University Science and Reserch Branch, Tehran, Iran.
Armity KiumarsyDepartment of Microbiology, Faculty of Advanced Science and Technology, Tehran Medical Science, Islamic Azad University, Tehran, Iran.
Mohammad Mahdi FeiziFaculty of Chemical Engineering, Amirkabir University of Technology, Tehran, Iran.
Zohreh VajdiFaculty of Engineering, University of Mohaghegh Ardabili, Ardabil, Iran.
Seyed Edalat PishkarDepartment of Biology, Faculty of Basic Science, Qods City Branch, Islamic Azad University, Tehran, Iran.
Mahsa AlemDepartment of Microbiology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran.
Esmaeil Roohparvar BasmenjBiophysics Department, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran. e.roohparvar@modares.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cholera is an acute, highly contagious diarrheal disease caused by the gram-negative bacterium Vibrio cholerae, typically contracted through contaminated water or food. Without timely treatment, cholera can lead to severe dehydration and death. The COVID-19 pandemic has underscored the critical importance of vaccine development, emphasizing the need for effective vaccines against various diseases. Despite the complexity and high costs associated with vaccine design, advancements in bioinformatics and immunoinformatics offer computational methods that accelerate research and provide valuable immunological insights. In this study, we utilized computational approaches to design a multi-epitope vaccine against V. cholerae. We started with the V. cholerae genome and identified 19,155 possible antigens, all of which underwent various computational filters to determine the best candidates. Finally, we identified the two best antigens for vaccine development. One of the key achievement of our study was the identification of these antigens, as they successfully passed all computational tests among all possible antigens. This finding may open new immunological pathways in designing vaccines against V. cholerae. These antigens served as the foundation for identifying B-cell, MHC I, and MHC II epitopes. Using linkers and an adjuvant, these epitopes formed the core components of our vaccine. The designed vaccine underwent multiple evaluations and successfully passed all assessments, demonstrating its potential efficacy.

Indexed as

CholeraCholera VaccinesEpitopesVibrio choleraeAnimalsAntigens, BacterialComputational BiologyCOVID-19Epitopes, B-LymphocyteEpitopes, T-LymphocyteHumansVaccine DevelopmentAntigens, BacterialCholera VaccinesEpitopesEpitopes, B-LymphocyteEpitopes, T-LymphocyteBioinformaticsEpitopeImmunoinformaticsVaccine candidateVibrio cholerae

Identifiers

PMID40164630
PMCPMC11958690

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.